According to the report published by Visiongain, the Arrhythmia Monitoring Devices market systems is projected at USD 6.18 billion in 2020. During the forecast period 2020-2030, expansion is expected at a CAGR of 6.5 percent fold. A variety of therapies for cardiac arrhythmia leadership, including integrated pacemakers, antiarrhythmic drugs, and implanted defibrillators, have been created. Selecting a suitable therapy path within a suitable timeframe is essential.
The digital revolution and the rapid development of smartphones, mobile communication and social networking have changed our lifestyle. With more than 90 percent of American teenagers having a cell phone and 55 percent having a smartphone, the average American is constantly connected to a vast data network and sophisticated digital phones via high bandwidth. Almost every industry and facet of our personal lives has been transformed by the digital revolution, but the universe of medicine has been conspicuously missing.
Doctors and health care networks were unwilling to adopt electronic medical records and integrate medical data with the global mobile device. However, fresh wireless monitoring technologies have lately emerged and have begun to be integrated into the therapy of cardiac nurses. We believe that the evolution of these wireless cardiac monitoring technologies will mark a new era in medicine and a shift from population-level health care to individualized medicine where suitable physicians are equipped with advanced biosensors to have their data evaluated before they occur through sophisticated algorithms to predict occurrences. This evaluation is intended to provide a thorough overview of the accessible novel cellular cardiac monitoring systems and the techniques presently under construction.
Real-time smart phone monitoring
Patients can now use a novel smartphone adapter to obtain and transmit single trace ECG data to their healthcare providers. Alivecor and ECG Check (Cardiac Designs) systems are single-lead (LeadI) FDA-approved ECG monitoring systems composed of a situation snapped at the bottom of a smartphone. In the case of the smartphone, the finger stress activates the bipolar factor I ECG playback and is transmitted from the screen to the smartphone using the frequency modulation of an ultrasound or Bluetooth signal acquired from the smartphone display. Once captured digitally in the smart phone it can be viewed in real-time and transmitted to a secure server for the patient’s provider to review in PDF format. The system has been validated in a number of settings including event monitoring and screening of atrial fibrillation.
Need for validation, cost-effectiveness
The rapid development of the hardware and software involved in the new generation of wireless cardiac monitoring devices has outpaced their real world validation and large-scale, pragmatic studies are needed to validate the enormous amounts of data generated from these monitors. Continuing clinical trials will be critical in determining the security, effectiveness and cost-effectiveness of this fresh technology compared to standard patient monitoring techniques. Furthermore, a much higher knowledge of employee variation in the adoption, commitment and efficiency of these techniques and the most suitable equilibrium of customer and supplier participation are crucial fields.
Biosensors will convey to their peripheral smartphone brain a riches of information on the patient’s genomic, metabolomic and clinical reactions to regular stimuli. Once the smartphone has been obtained, the data will be processed using advanced and personalized modeling software and guide the client to follow initiative; whether to email their physician, adjust a medication, or alert EMS to an imminent myocardial infarction. These tools are capable of revolutionizing medicine. In the coming years, the possible incorporation and research of these systems must examine closely not only the comparative safety and efficacy of this technology compared to standard treatment, but also the impact of this technology on changing the costs of healthcare by preventing rehospitalization and empowering patients.
Advances in wearable cardiac monitoring technology are enhancing both the patient’s knowledge and clinicians ‘ efficiency in gathering information and analyzing ECG-based heart exercise. While earlier cardiac monitoring techniques have led in poor patient compliance and late access to hospital information, fresh cardiac monitoring technology is less patient-friendly, providing clinicians with instant access to and assessment of ECG information from physicians.
Why you should buy Arrhythmia Monitoring Devices Market Forecast 2020-2030: Forecasts and Analysis by Type (ECG, Implantable, Holter, Mobile Cardiac Telemetry), By Application, By End Use
and Geography, with Profiles of Leading Companies
What is the future of the Arrhythmia Monitoring Devices market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information –
– View Arrhythmia Monitoring Devices market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Arrhythmia Monitoring Devices revenue forecast
– Arrhythmia Monitoring Devices connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Arrhythmia Monitoring Devices market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Arrhythmia Monitoring Devices sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Arrhythmia Monitoring Devices industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Arrhythmia Monitoring Devices submarkets with individual forecasts and analysis from 2020-2030.
– Type submarket forecast 2020-2030
– Application submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– Learn about the market prospects for the leading Arrhythmia Monitoring Devices market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Arrhythmia Monitoring Devices revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Type Revenue Forecast 2020-2030
– Mobile Cardiac Telemetry Devices Market Forecast, 2020-2030
– Implantable Cardiac Monitors Market Forecast, 2020-2030
– Resting ECG Devices Market Forecast, 2020-2030
– ECG Stress Test Devices Market Forecast, 2020-2030
– Holter Monitors Market Forecast, 2020-2030
– Other Type Market Forecast, 2020-2030
– Application Revenue Forecast 2020-2030
– Tachycardia Market Forecast, 2020-2030
– Bradycardia Market Forecast, 2020-2030
– Atrial Fibrillation Market Forecast, 2020-2030
– Ventricular Fibrillation Market Forecast, 2020-2030
– Premature Contraction Market Forecast, 2020-2030
– Conduction disorders Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Hospitals & Clinics Market Forecast, 2020-2030
– Diagnostic Centers Market Forecast, 2020-2030
– Ambulatory Surgery Centers Market Forecast, 2020-2030
– Diagnostic Centers Market Forecast, 2020-2030
– Homecare Settings Market Forecast, 2020-2030
– long term care centers Market Forecast, 2020-2030
– Emergency Medical services Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Arrhythmia Monitoring Devices markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Arrhythmia Monitoring Devices companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Arrhythmia Monitoring Devices revenue forecast 2020-2030
– US Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Canada Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Mexico Arrhythmia Monitoring Devices revenue forecast 2020-2030
– North America Arrhythmia Monitoring Devices by Type revenue forecast 2020-2030
– North America Arrhythmia Monitoring Devices by Application revenue forecast 2020-2030
– North America Arrhythmia Monitoring Devices by End-Use revenue forecast 2020-2030
– Asia Pacific Arrhythmia Monitoring Devices revenue forecast 2020-2030
– China Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Japan Arrhythmia Monitoring Devices revenue forecast 2020-2030
– India Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Australia Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Rest of Asia Pacific Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Asia Pacific Arrhythmia Monitoring Devices by Type revenue forecast 2020-2030
– Asia Pacific Arrhythmia Monitoring Devices by Application revenue forecast 2020-2030
– Asia Pacific Arrhythmia Monitoring Devices by End-Use revenue forecast 2020-2030
– European Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Germany Arrhythmia Monitoring Devices revenue forecast 2020-2030
– UK Arrhythmia Monitoring Devices revenue forecast 2020-2030
– France Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Italy Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Spain Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Rest of Europe Arrhythmia Monitoring Devices revenue forecast 2020-2030
– European Arrhythmia Monitoring Devices by Type revenue forecast 2020-2030
– European Arrhythmia Monitoring Devices by Application revenue forecast 2020-2030
– European Arrhythmia Monitoring Devices by End-Use revenue forecast 2020-2030
– Rest of World Arrhythmia Monitoring Devices revenue forecast 2020-2030
– Rest of World Arrhythmia Monitoring Devices by Type revenue forecast 2020-2030
– Rest of World Arrhythmia Monitoring Devices by Application revenue forecast 2020-2030
– Rest of World Arrhythmia Monitoring Devices by End-Use revenue forecast 2020-2030
– Explore the factors affecting Arrhythmia Monitoring Devices product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Arrhythmia Monitoring Devices industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Arrhythmia Monitoring Devices companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Arrhythmia Monitoring Devices Market
BioTelemetry, Inc.
Applied Cardiac Systems
AliveCor, Inc.
Medi-Lynx
iRhythm
Fukuda Denshi Co., Ltd.
BIOTRONIK
NUUBO Smart Solutions Technologies, SL
Koninklijke Philips N.V.
GE Healthcare (General Electric Company)
Discover Information found nowhere else in this independent assessment of the Arrhythmia Monitoring Devices market
The Arrhythmia Monitoring Devices Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By End-Use and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Arrhythmia Monitoring Devices sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Arrhythmia Monitoring Devices Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By End-Use and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Arrhythmia Monitoring Devices market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Arrhythmia Monitoring Devices sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Arrhythmia Monitoring Devices Market Forecast 2020-2030: Forecasts and Analysis By Type, By Application, By End-Use and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Arrhythmia Monitoring Devices sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Arrhythmia Monitoring Devices Market Definition
1.2 Global Arrhythmia Monitoring Devices Market Overview
1.3 Global Arrhythmia Monitoring Devices Market Segmentation
1.4 Research Scope of Arrhythmia Monitoring Devices in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Arrhythmia Monitoring Devices Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
2.4.2 Expanding geriatric population base coupled with growing prevalence of obesity
2.4.3 Growing prevalence of cardiovascular diseases and expenditure on cardiac health globally
2.4.4 Negative effects of some cardiac monitoring devices on patients
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Arrhythmia Monitoring Devices Market Analysis
3.1 PEST Analysis of the Arrhythmia Monitoring Devices Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Arrhythmia Monitoring Devices Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Arrhythmia Monitoring Devices: Global Market Analysis by Segments
4.1 Global Arrhythmia Monitoring Devices Market Forecast, by Type 2020-2030
4.1.1 Type Overview
4.1.2 Mobile Cardiac Telemetry Devices Market Forecast, 2020-2030
4.1.3 Implantable Cardiac Monitors Market Forecast, 2020-2030
4.1.4 Resting ECG Devices Market Forecast, 2020-2030
4.1.5 ECG Stress Test Devices Market Forecast, 2020-2030
4.1.6 Holter Monitors Market Forecast, 2020-2030
4.1.7 Other Type Market Forecast, 2020-2030
4.2 Global Arrhythmia Monitoring Devices Market Forecast, by Application 2020-2030
4.2.1 Application Overview
4.2.2 Tachycardia Market Forecast, 2020-2030
4.2.3 Bradycardia Market Forecast, 2020-2030
4.2.4 Atrial Fibrillation Market Forecast, 2020-2030
4.2.5 Ventricular Fibrillation Market Forecast, 2020-2030
4.2.6 Premature Contraction Market Forecast, 2020-2030
4.2.7 Conduction disorders Market Forecast, 2020-2030
4.3 Global Arrhythmia Monitoring Devices Market Forecast, by End-Use 2020-2030
4.3.1 End-Use Overview
4.3.2 Hospitals & Clinics Market Forecast, 2020-2030
4.3.3 Diagnostic Centers Market Forecast, 2020-2030
4.3.4 Ambulatory Surgery Centers Market Forecast, 2020-2030
4.3.5 Diagnostic Centers Market Forecast, 2020-2030
4.3.6 Homecare Settings Market Forecast, 2020-2030
4.3.7 long term care centers Market Forecast, 2020-2030
4.3.8 Emergency Medical services Market Forecast, 2020-2030
4.3.9 Other End-Use Market Forecast, 2020-2030
5. Leading Regions in Arrhythmia Monitoring Devices Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Arrhythmia Monitoring Devices Market Forecast, 2020-2030
5.2.1 North America Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
5.2.2 North America Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030
5.2.3 North America Arrhythmia Monitoring Devices Submarket, By End-Use Forecast 2020-2030
5.2.4 North America Arrhythmia Monitoring Devices Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.2.4.2 Canada Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.2.4.3 Mexico Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3 Europe Arrhythmia Monitoring Devices Market Forecast, 2020-2030
5.3.1 Europe Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
5.3.2 Europe Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030
5.3.3 Europe Arrhythmia Monitoring Devices Submarket, By End-Use Forecast 2020-2030
5.3.4 Europe Arrhythmia Monitoring Devices Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.2 Germany Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.3 France Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.4 Italy Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.5 Spain Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.6 The Netherlands Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4 Asia-Pacific Arrhythmia Monitoring Devices Market Forecast, 2020-2030
5.4.1 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
5.4.2 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030
5.4.3 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By End-Use Forecast 2020-2030
5.4.4 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Country Forecast 2020-2030
5.4.4.1 China Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.2 India Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.3 Japan Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.4 Korea Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.5 Indonesia Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.6 Australia Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Arrhythmia Monitoring Devices Market, Forecast 2020-2030
5.5 Rest of World Arrhythmia Monitoring Devices Market Forecast, 2020-2030
5.5.1 Rest of World Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
5.5.2 Rest of World Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030
5.5.3 Rest of World Arrhythmia Monitoring Devices Submarket, By End-Use Forecast 2020-2030
6. Leading Companies in The Arrhythmia Monitoring Devices Market
6.1 BioTelemetry, Inc.
6.1.1 BioTelemetry, Inc. Overview
6.1.2 Analysis of BioTelemetry, Inc. Products and Services
6.1.3 BioTelemetry, Inc. Primary Market Competitors 2019
6.1.4 BioTelemetry, Inc. Key Developments
6.2 Applied Cardiac Systems
6.2.1 Applied Cardiac Systems Company Overview
6.2.2 Analysis of Applied Cardiac Systems Products and Services
6.2.3 Applied Cardiac Systems Primary Market Competitors 2019
6.2.4 Applied Cardiac Systems Key Developments
6.3 AliveCor, Inc.
6.3.1 AliveCor, Inc. Company Overview
6.3.2 Analysis of AliveCor, Inc. Products and Services
6.3.3 AliveCor, Inc. Primary Market Competitors 2019
6.3.4 AliveCor, Inc. Key Developments
6.4 Medi-Lynx
6.4.1 Medi-Lynx Company Overview
6.4.2 Analysis of Medi-Lynx Products and Services
6.4.3 Medi-Lynx Primary Market Competitors 2019
6.4.4 Medi-Lynx Key Developments
6.5 iRhythm
6.5.1 iRhythm Company Overview
6.5.2 Analysis of iRhythm Products and Services
6.5.3 iRhythm Primary Market Competitors 2019
6.5.4 iRhythm Key Developments
6.6 Fukuda Denshi Co., Ltd.
6.6.1 Fukuda Denshi Co., Ltd. Company Overview
6.6.2 Analysis of Fukuda Denshi Co., Ltd. Products and Services
6.6.3 Fukuda Denshi Co., Ltd. Primary Market Competitors 2019
6.6.4 Fukuda Denshi Co., Ltd. Key Developments
6.7 BIOTRONIK
6.7.1 BIOTRONIK Company Overview
6.7.2 Analysis of BIOTRONIK Products and Services
6.7.3 BIOTRONIK Primary Market Competitors 2019
6.7.4 BIOTRONIK Key Developments
6.8 NUUBO Smart Solutions Technologies, SL
6.8.1 NUUBO Smart Solutions Technologies, SL Company Overview
6.8.2 Analysis of NUUBO Smart Solutions Technologies, SL Products and Services
6.8.3 NUUBO Smart Solutions Technologies, SL Primary Market Competitors 2019
6.8.4 NUUBO Smart Solutions Technologies, SL Key Developments
6.9 Koninklijke Philips N.V.
6.9.1 Koninklijke Philips N.V. Company Overview
6.9.2 Analysis of Koninklijke Philips N.V. Products and Services
6.9.3 Koninklijke Philips N.V. Primary Market Competitors 2019
6.9.4 Koninklijke Philips N.V. Key Developments
6.10 GE Healthcare
6.10.1 GE Healthcare Company Overview
6.10.2 Analysis of GE Healthcare Products and Services
6.10.3 GE Healthcare Primary Market Competitors 2019
6.10.4 GE Healthcare Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Arrhythmia Monitoring Devices Market Segmentation
Figure 2.1 Arrhythmia Monitoring Devices Value Chain Analysis
Figure 3.1 Arrhythmia Monitoring Devices Supply-Demand Analysis
Figure 4.1 Global Arrhythmia Monitoring Devices Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Arrhythmia Monitoring Devices Market Forecast 2020-2030
Figure 4.3 Global Arrhythmia Monitoring Devices Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Arrhythmia Monitoring Devices Market By Type Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Arrhythmia Monitoring Devices by Submarket By Type Forecast 2020-2030 ($ million)
Figure 4.20 Global Arrhythmia Monitoring Devices Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Arrhythmia Monitoring Devices Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Arrhythmia Monitoring Devices Market, By End-Use System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Arrhythmia Monitoring Devices Market, By Type Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Arrhythmia Monitoring Devices Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Arrhythmia Monitoring Devices Market, by 2020-2030
Figure 5.3 Leading Country/Regional Arrhythmia Monitoring Devices Market Share, by 2020
Figure 5.4 Leading Country/Regional Arrhythmia Monitoring Devices Market Share, by 2025
Figure 5.5 Leading Country/Regional Arrhythmia Monitoring Devices Market Share, by 2030
Figure 5.6 Europe Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Arrhythmia Monitoring Devices Market, by Forecast 2020-2030
Figure 5.8 Europe Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
Figure 5.9 Europe Arrhythmia Monitoring Devices Submarket , By Application Forecast 2020-2030
Figure 5.10 Europe Arrhythmia Monitoring Devices Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Arrhythmia Monitoring Devices Submarket , By End-Use 2020-2030 ($billion, AGR%)
Figure 5.10 North America Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Arrhythmia Monitoring Devices Market, by Forecast 2020-2030
Figure 5.12 North America Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
Figure 5.13 North America Arrhythmia Monitoring Devices Submarket , By Application Forecast 2020-2030
Figure 5.14 North America Arrhythmia Monitoring Devices Submarket , By End-Use Forecast 2020-2030
Figure 5.13 North America Arrhythmia Monitoring Devices Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Arrhythmia Monitoring Devices Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
Figure 5.17 Asia-Pacific Arrhythmia Monitoring Devices Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Arrhythmia Monitoring Devices Submarket , By End-Use Forecast 2020-2030
Figure 5.18 Rest of World Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Arrhythmia Monitoring Devices Market, by Forecast 2020-2030
Figure 5.20 Rest of World Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030
Figure 5.21 Rest of World Arrhythmia Monitoring Devices Submarket , By Application Forecast 2020-2030
Figure 5.21 Rest of World Arrhythmia Monitoring Devices Submarket , By End-Use Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Applied Cardiac Systems Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 AliveCor, Inc. Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Medi-Lynx Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Medi-Lynx Revenue % Share, by End-Use Segment, 2019
Figure 6.8 Medi-Lynx Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Medi-Lynx Revenue % Share, by Business Segment, 2019
Figure 6.10 iRhythm Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Fukuda Denshi Co., Ltd. Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 BIOTRONIK Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 BIOTRONIK Revenue % Share, by Regional Segment, 2019
Figure 6.14 NUUBO Smart Solutions Technologies, SL Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 NUUBO Smart Solutions Technologies, SL Revenue % Share, by Regional Segment, 2019
Figure 6.16 NUUBO Smart Solutions Technologies, SL Revenue % Share, by Business Segment, 2019
Figure 6.17 Koninklijke Philips N.V. Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 GE Healthcare Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 GE Healthcare Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 GE Healthcare Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Arrhythmia Monitoring Devices Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Arrhythmia Monitoring Devices Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Arrhythmia Monitoring Devices Market Submarket, By End-Use Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Arrhythmia Monitoring Devices Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Arrhythmia Monitoring Devices Market Submarket, By End-Use Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Arrhythmia Monitoring Devices Submarket, By Type Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Arrhythmia Monitoring Devices Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Applied Cardiac Systems Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Applied Cardiac Systems Products and Services (Product/Service, Segment)
Table 6.8 Applied Cardiac Systems Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Applied Cardiac Systems Total Company Recent Development 2015-2019
Table 6.10 AliveCor, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 AliveCor, Inc. Products and Services (Product/Service, Segment)
Table 6.12 AliveCor, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 AliveCor, Inc. Total Company Recent Development 2015-2019
Table 6.14 Medi-Lynx Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Medi-Lynx Products and Services (Product/Service, Segment)
Table 6.16 Medi-Lynx Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Medi-Lynx Total Company Recent Development 2015-2019
Table 6.18 iRhythm Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 iRhythm Products and Services (Product/Service, Segment)
Table 6.20 iRhythm Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 iRhythm Total Company Recent Development 2015-2019
Table 6.22 Fukuda Denshi Co., Ltd. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Fukuda Denshi Co., Ltd. Products and Services (Product/Service, Segment)
Table 6.24 Fukuda Denshi Co., Ltd. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Fukuda Denshi Co., Ltd. Total Company Recent Development 2015-2019
Table 6.26 BIOTRONIK Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 BIOTRONIK Products and Services (Product/Service, Segment)
Table 6.28 BIOTRONIK Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 BIOTRONIK Total Company Recent Development 2015-2019
Table 6.30 NUUBO Smart Solutions Technologies, SL Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 NUUBO Smart Solutions Technologies, SL Products and Services (Product/Service, Segment)
Table 6.32 NUUBO Smart Solutions Technologies, SL Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 NUUBO Smart Solutions Technologies, SL Total Company Recent Development 2015-2019
Table 6.34 Koninklijke Philips N.V. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Koninklijke Philips N.V. Products and Services (Product/Service, Segment)
Table 6.36 Koninklijke Philips N.V. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Koninklijke Philips N.V. Total Company Recent Development 2015-2019
Table 6.38 GE Healthcare Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 GE Healthcare Products and Services (Product/Service, Segment)
Table 6.40 GE Healthcare Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 GE Healthcare Total Company Recent Development 2015-2019